Systemic lupus erythematosus and ulcerative colitis: an uncommon association.
Garcia-Porrua
C
C
Gonzalez-Gay
M A
MA
Lancho
A
A
Alvarez-Ferreira
J
J
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000473:pathology; D003093:Colitis, Ulcerative / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D003106:Colon / Q000473:pathology; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004848:Epithelium / Q000473:pathology; D006801:Humans; D007413:Intestinal Mucosa / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D019804:Mesalamine / Q000627:therapeutic use; D008875:Middle Aged; D009504:Neutrophils / Q000473:pathology; D011239:Prednisolone / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D019804:Mesalamine; D011239:Prednisolone